Schedule 13G ownership disclosure
LION BIOTECHNOLOGIES
Security class unavailable · CUSIP: 53619R102
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,000,161
- Percent of class
- 6.2700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-16-001120
- Form type
- SC 13G
- Filer
- IOVANCE BIOTHERAPEUTICS, INC.
- CIK
- CIK 1425205
- Filed
- Feb 16, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership